Project Grant R01HL178395
Award Date 9/15/25
Completion Date 6/30/30
Dollars Obligated $712K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- This $165,353 Project Grant was awarded on September 25, 2025 by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The grant funding will support research to define the association between severe obesity and regional lung perfusion, as well as test the effect of severe obesity on pulmonary vasoreactivity in patients with acute hypoxemic respiratory failure....
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $372,307 Project Grant award from the U.S. Department of Health and Human Services' Fogarty International Center (CFDA 93.989 - International Research and Research Training) on September 9, 2025. The grant supports a collaborative project with the Ignace Hospital in Guinea and three rural Guinea sites to build capacity for the diagnosis and treatment of neuromyelitis optica (NMO) using...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $161,169 Project Grant by the Office of the Director at the National Institutes of Health under the Research Infrastructure Programs (CFDA 93.351) to purchase a state-of-the-art metabolic/gas exchange system compatible with magnetic resonance imaging (MRI). This specialized equipment will enable a wide range of breath-by-breath gas exchange and pulmonary function measurements as well as...
- The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, awarded a $1,127,798 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). This 7-year grant, effective February 1, 2025, will support research to understand the role of macrophages in preserving cardiovascular health, illuminating their contributions to cardiovascular disease, and...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $170,640 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), on August 15, 2025. The grant supports research by Dr. Tristan Kooistra, a physician-scientist at MGH and Harvard Medical School, to investigate how epithelial-derived Notch signals promote the maturation of airway macrophages and influence allergic...
- The Project Grant award of $759,658 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research at The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop and validate a mechanomicroscopy imaging platform for the transbronchial assessment of pulmonary artery pressure and arterial smooth muscle thickening in patients with pulmonary hypertension due to lung disease. The key products and services to be...
- The National Heart, Lung, and Blood Institute, under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $700,857 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct research on "Imaging the Respiratory Effects of Truncal Adiposity in Acute Hypoxemic Respiratory Failure." The project aims to use computed tomography (CT) imaging to investigate how the magnitude and distribution of truncal adiposity (excess fat...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $170,640 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on the role of the airway hillock cell type in airway barrier function and regeneration. The award period runs from September 15, 2025 to August 31, 2030. The research aims to define the mechanisms by which the hillock cell resists injury and...
- The National Institute of Environmental Health Sciences (NIEHS) awarded a $215,195 Project Grant under the Environmental Health federal grant program (CFDA 93.113) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the "AIR POLLUTION AND WELL-BEING: ASSESSING RISKS AND ENHANCING EDUCATION IN UGANDA (AWARE STUDY)" project. This project aims to characterize local knowledge, attitudes, and perceptions about air pollution and health among...